Clinical Trials on Glabellar Crease
Total 10000 results
-
Centre Henri BecquerelUnknownTolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer (EPIC)Early Stage Breast CarcinomaFrance
-
PrECOG, LLC.NovartisCompletedMetastatic Breast CancerUnited States
-
Western Regional Medical CenterTerminated
-
Samsung Medical CenterUnknownBreast Cancer Stage IVKorea, Republic of
-
University of California, DavisNational Cancer Institute (NCI)Completed
-
RWTH Aachen UniversityUniv.-Prof. Dr. med. F. KiesslingUnknown
-
Zhiyong YuUnknownBreast Cancer | Chemotherapy | Endocrine Breast Diseases
-
Juravinski Cancer CenterCompletedEarly Stage Breast CancerCanada
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedEarly-Stage Breast CancerUnited States
-
Centre Francois BaclesseNational Cancer Institute, France; ARC Foundation for Cancer ResearchTerminatedMetastatic Breast Cancer | PostmenopausalFrance
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
Memorial Sloan Kettering Cancer CenterPfizer; AmgenCompletedDose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityBreast Cancer | Adenocarcinoma of the BreastUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedLocally Advanced Breast CancerUnited States
-
Karolinska University HospitalCompletedPostoperative Radiotherapy Breast CancerSweden
-
HaEmek Medical Center, IsraelTerminatedChemotherapy | Breast Cancer, MetastaticIsrael
-
National Cancer Institute, ThailandVichaiyut HospitalWithdrawnCarcinoma Breast Stage IVThailand
-
PfizerTerminatedInvasive Early Breast CancerRomania
-
University of MagdeburgBoehringer IngelheimTerminated
-
Ontario Clinical Oncology Group (OCOG)Juravinski Cancer Centre FoundationCompleted
-
Eli Lilly and CompanyCompletedMetastatic Breast Cancer (MBC)Italy
-
University of VermontUnknownStage I Breast CancerUnited States
-
Association Européenne de Recherche en OncologieAmgen; Aventis PharmaceuticalsCompletedNode Positive Breast Cancer
-
Fudan UniversityRecruitingTNBC, Triple Negative Breast CancerChina
-
Helwan UniversityNot yet recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
-
Zhejiang Cancer HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Not yet recruitingFemale Breast Cancer Patients | Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer | HRD Positive Advanced Breast Cancer
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBreast Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast CarcinomaUnited States, Puerto Rico
-
Columbia UniversityActive, not recruitingTriple Negative Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Peking University Cancer Hospital & InstituteActive, not recruitingBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | HR+, HER2-, Advanced Breast CancerChina
-
European Organisation for Research and Treatment...AstraZenecaWithdrawnBRCA1 Mutation | BRCA2 Mutation | TNBC - Triple-Negative Breast Cancer
-
Mayo ClinicRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Hormone Receptor-Positive Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Adult Solid NeoplasmUnited States
-
University of UtahRecruitingBreast Cancer | Ductal Breast Carcinoma in Situ | Invasive Carcinoma of BreastUnited States
-
Tianjin Medical University Cancer Institute and...Not yet recruitingAdvanced Breast Cancer | HER2 + Breast Cancer | HER2positiveChina
-
Atlas UniversityNot yet recruitingBreast Cancer | Locally Advanced Breast Cancer (LABC)Turkey (Türkiye)
-
University of Vermont Medical CenterNot yet recruitingBreast Cancer | HER-2 Positive Breast CancerUnited States
-
Norwegian Institute of Public HealthVestre Viken Hospital Trust; Oslo University Hospital; University Hospital, Akershus and other collaboratorsNot yet recruitingBreast Cancer | Risk Stratification | Mammographic Breast Density
-
Hoffmann-La RocheRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerChina
-
Portsmouth Hospitals NHS TrustUniversity of PortsmouthRecruitingBreast Cancer PatientsUnited Kingdom
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingAdvanced Breast Cancer
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Recruiting
-
Ana Trigueros MurilloNot yet recruitingBreast Cancer SurvivorsSpain
-
Fudan UniversityNot yet recruitingAdvanced Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Esbjerg Hospital - University Hospital of Southern...Odense University Hospital; Aarhus University Hospital; University of Copenhagen and other collaboratorsRecruitingEarly Breast CancerDenmark
-
European Institute of OncologyRecruitingMetastatic Breast CancerItaly
-
Baker Heart and Diabetes InstituteNot yet recruitingBreast Cancer SurvivorshipAustralia
-
Jan ŽateckýRecruitingBreast Cancer SurgeryCzech Republic
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
UNC Lineberger Comprehensive Cancer CenterPfizerRecruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI); University of Pennsylvania; Duke UniversityRecruitingMetastatic Breast CancerUnited States